ABT-348 as Monotherapy or Combination With Carboplatin or Docetaxel to Treat Advanced Solid Tumors

NCT01110486 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

102

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: ABT-348
DRUG: ABT-348 and carboplatin
DRUG: ABT-348 and docetaxel
DRUG: ABT-348
DRUG: ABT-348

Sponsor

AbbVie (prior sponsor, Abbott)